Moderna said a vaccine against the Omicron strain could be ready in early 2022. This was stated by the chief medical officer of Moderna Inc. Paul Burton, reports Bloomberg.
“We need to be aware of the ability of the current vaccine to provide protection over the next few weeks. If we have to make a completely new vaccine, I think it will take place in early 2022 before it is available in large quantities,” he said.
It is noted that the currently available vaccines will probably not affect the new Omicron coronavirus strain. But before the drug is made for safety, it is necessary to vaccinate with existing vaccines.
Moderna is currently testing a current vaccine against a new variant of the virus.
Earlier British scientists discovered a new strain of coronavirus - B.1.1.529, which contains 32 mutations in the spike protein. The virus uses this part to enter the cell of the body with its subsequent infection. The characteristics of the B.1.1.529 virus could give rise to serious concern among scientists about the hazard of this strain.
Subsequently, WHO announced that it was organizing a special meeting to discuss the new strain of coronavirus.
The result of the meeting was the name Omicron given to the SARS-CoV-2 coronavirus B.1.1.529 strain with 32 mutations.
Pfizer and BioNTech soon announced a plan to adapt their mRNA vaccine to the new Omicron strain.
A new strain of coronavirus has already been found in the Republic of South Africa, Belgium, Israel, Germany, Italy, Austria, Great Britain.